News
IART
11.06
+8.01%
0.82
Weekly Report: what happened at IART last week (0406-0410)?
Weekly Report · 1d ago
Integra unveils real-world PriMatrix data from 985 cases across 117 surgeons
Reuters · 04/07 12:33
Citi Reaffirms Their Sell Rating on Integra Lifesciences (IART)
TipRanks · 04/07 11:26
Integra LifeSciences announces annual shareholder meeting
Reuters · 04/06 20:46
Weekly Report: what happened at IART last week (0330-0403)?
Weekly Report · 04/06 10:18
Weekly Report: what happened at IART last week (0323-0327)?
Weekly Report · 03/30 10:19
Weekly Report: what happened at IART last week (0316-0320)?
Weekly Report · 03/23 10:15
Organon leads ultra-low P/E stocks at 1.8x as small-cap stocks face volatility
Seeking Alpha · 03/18 17:25
Integra LifeSciences assumed with an Equal Weight at Wells Fargo
TipRanks · 03/18 10:26
Weekly Report: what happened at IART last week (0309-0313)?
Weekly Report · 03/16 10:14
Why Integra LifeSciences (IART) Shares Are Sliding Today
Barchart · 03/12 15:04
Integra LifeSciences Price Target Cut to $9.00/Share From $11.00 by Citigroup
Dow Jones · 03/11 15:53
Integra LifeSciences Is Maintained at Sell by Citigroup
Dow Jones · 03/11 15:53
Weekly Report: what happened at IART last week (0302-0306)?
Weekly Report · 03/09 10:15
Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know
Barchart · 03/06 13:32
Integra LifeSciences Holdings is Now Oversold (IART)
NASDAQ · 03/05 17:06
Integra’s MicroMatrix Flex Study Reaches Completion, Setting Up Next Steps for IART Investors
TipRanks · 03/05 16:31
Integra Lifesciences (IART) Receives a Hold from Truist Financial
TipRanks · 03/02 13:06
Integra Q4 Earnings & Revenues Beat Estimates, Margins Down, Stock Up
NASDAQ · 03/02 12:41
Weekly Report: what happened at IART last week (0223-0227)?
Weekly Report · 03/02 10:14
More
Webull provides a variety of real-time IART stock news. You can receive the latest news about Integra Lifesciences Hldgs Cp through multiple platforms. This information may help you make smarter investment decisions.
About IART
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.